PRTT

Protect Pharmaceutical Corporation

USD

Set alert

Price alert · PRTT

All alert types
0.08 USD 0.00 0.00%
As of Oct 30, 2026
0.07 Day range 0.075
0.018 52-week range 0.62
YTD
-18.48%
1 year
-62.50%
Open
0.07
Prev close
0.075
Mkt cap
4.31M
Vol
44.96K
Avg vol
11.73K
EPS
0.00
P/E
0.00
More statistics
Low
0.07
High
0.075

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for PRTT has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.94 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.0×
FY 2016: -26.7×FY 2017: -7.3×FY 2018: 0.0×FY 2019: -6748×FY 2020: 10.9×FY 2021: 1.1×FY 2022: 0.3×FY 2023: 3.2×FY 2024: 0.6×FY 2025: -0.0×
FY 2016 5y median 0.6× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 11.1×FY 2021: 0.3×FY 2022: 0.1×FY 2023: 1.1×FY 2024: 0.2×FY 2025: 0.0×
FY 2016 5y median 0.2× FY 2025
P/B 0.0×
FY 2016: -53.4×FY 2017: -6.2×FY 2018: 0.0×FY 2019: -233×FY 2020: 11.2×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.5×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
P/FCF 0.0×
FY 2016: -78.5×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 1055×FY 2020: -5.1×FY 2021: -0.3×FY 2022: -0.1×FY 2023: 0.0×FY 2024: 3.2×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
EV/EBITDA 0.0×
FY 2016: 0.0×FY 2017: 2475×FY 2018: 0.0×FY 2019: -6759×FY 2020: 13.7×FY 2021: -0.2×FY 2022: 0.4×FY 2023: 2.8×FY 2024: 0.3×FY 2025: 0.0×
FY 2016 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 13.5×FY 2021: -0.1×FY 2022: 0.1×FY 2023: 1.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
FCF Yield 0.0%
FY 2016: -1.3%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.1%FY 2020: -19.8%FY 2021: -288.4%FY 2022: -871.8%FY 2023: 0.0%FY 2024: 31.3%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 98.7%FY 2021: 56.3%FY 2022: 50.8%FY 2023: 53.8%FY 2024: 54.9%FY 2025: 0.0%
FY 2016 5y median 53.8% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 97.9%FY 2021: 35.4%FY 2022: 30.9%FY 2023: 34.9%FY 2024: 43.6%FY 2025: 0.0%
FY 2016 5y median 34.9% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 97.8%FY 2021: 25.6%FY 2022: 27.4%FY 2023: 33.7%FY 2024: 42.6%FY 2025: 0.0%
FY 2016 5y median 27.4% FY 2025
ROE 0.0%
FY 2016: 200.2%FY 2017: 85.7%FY 2018: 0.0%FY 2019: 3.5%FY 2020: 98.7%FY 2021: 9.8%FY 2022: 9.8%FY 2023: 16.6%FY 2024: 16.9%FY 2025: 0.0%
FY 2016 5y median 9.8% FY 2025
ROIC 0.0%
FY 2016: 200.0%FY 2017: 270.7%FY 2018: 0.0%FY 2019: -2.4%FY 2020: 29.1%FY 2021: 9.3%FY 2022: 9.6%FY 2023: 16.4%FY 2024: 16.7%FY 2025: 0.0%
FY 2016 5y median 9.6% FY 2025
ROA 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -1.3%FY 2020: 29.0%FY 2021: 5.5%FY 2022: 6.5%FY 2023: 12.5%FY 2024: 13.5%FY 2025: 0.0%
FY 2016 5y median 6.5% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 1226.3%FY 2022: 3.8%FY 2023: 66.5%FY 2024: -2.9%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -100.0%
FY 2016: -38.9%FY 2017: -175.7%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 311034.2%FY 2021: 379.5%FY 2022: -9.4%FY 2023: 88.2%FY 2024: 21.2%FY 2025: -100.0%
FY 2016 FY 2025
EPS (diluted) -690.8%
FY 2016: 97.2%FY 2017: -150.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 227.3%FY 2022: 19.4%FY 2023: 86.0%FY 2024: 22.5%FY 2025: -690.8%
FY 2016 FY 2025
Free Cash Flow 0.0%
FY 2016: 20.5%FY 2017: 100.0%FY 2018: 0.0%FY 2019: 133.2%FY 2020: -108874.2%FY 2021: -398.2%FY 2022: -6.3%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 1.5×FY 2021: 1.0×FY 2022: 1.6×FY 2023: 2.4×FY 2024: 3.1×FY 2025: 0.0×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 1.5×FY 2021: 0.6×FY 2022: 0.8×FY 2023: 1.4×FY 2024: 1.7×FY 2025: 0.0×
FY 2016 5y median 0.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: -0.7×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 2.4×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: 0.0×FY 2017: 253×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 2.4×FY 2021: -1.0×FY 2022: 0.1×FY 2023: -0.3×FY 2024: -0.2×FY 2025: 0.0×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -15.9×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 4229×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31